These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24228408)
1. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 1) Abnormalities in hematopoietic stem cells: congenital immunodeficiencies]. Hara T Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2255-61. PubMed ID: 24228408 [No Abstract] [Full Text] [Related]
2. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; introduction]. Akashi K; Ueda T Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2254. PubMed ID: 24228407 [No Abstract] [Full Text] [Related]
3. A history of bone marrow transplantation. de la Morena MT; Gatti RA Immunol Allergy Clin North Am; 2010 Feb; 30(1):1-15. PubMed ID: 20113883 [TBL] [Abstract][Full Text] [Related]
4. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 5) Stem cell disorders and epigenetics]. Shimono Y Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2279-83. PubMed ID: 24228412 [No Abstract] [Full Text] [Related]
5. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 2) Human leukemic stem cell]. Akashi K Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2262-6. PubMed ID: 24228409 [No Abstract] [Full Text] [Related]
6. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 4) The intestinal epithelial stem cells and cancer stem cells]. Tsuchiya K Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2273-8. PubMed ID: 24228411 [No Abstract] [Full Text] [Related]
7. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 3) iPS cell technology for neurodegenerative disease]. Inoue H Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2267-72. PubMed ID: 24228410 [No Abstract] [Full Text] [Related]
8. [Viruses as a cause of secondary immunodeficiencies in animals]. Makarov VV; Chebelev SF Vopr Virusol; 1984; 29(2):148-52. PubMed ID: 6375135 [No Abstract] [Full Text] [Related]
9. Are T gamma of myelomonocytic lineage? Astaldi A; Van de Griend RJ; Schellekens PT; Vossen JM Eur J Immunol; 1982 Jun; 12(6):527-30. PubMed ID: 6214409 [No Abstract] [Full Text] [Related]
10. Long-term in vivo cell surface expression of human CD18 in murine hematopoietic cells. Krauss JC; Mayo-Bond L; Rogers CE; Weber KL; Todd RF; Wilson JM Trans Assoc Am Physicians; 1991; 104():131-40. PubMed ID: 1688259 [No Abstract] [Full Text] [Related]
11. Transplantation of hematopoietic cells for lethal congenital immunodeficiencies. O'Reilly RJ; Kapoor N; Kirkpatrick D; Flomenberg N; Pollack MS; Dupont B; Good RA; Reisner Y Birth Defects Orig Artic Ser; 1983; 19(3):129-37. PubMed ID: 6140037 [No Abstract] [Full Text] [Related]
12. Reduced intensity transplantation for primary immunodeficiency disorders. Veys P Immunol Allergy Clin North Am; 2010 Feb; 30(1):103-24. PubMed ID: 20113889 [TBL] [Abstract][Full Text] [Related]